These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8183234)

  • 21. In vivo labeling of nicotinic acetylcholine receptors in brain with [3H]epibatidine.
    London ED; Scheffel U; Kimes AS; Kellar KJ
    Eur J Pharmacol; 1995 May; 278(1):R1-2. PubMed ID: 7664806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain cyclooxygenase and prostanoid TP receptors are involved in centrally administered epibatidine-induced secretion of noradrenaline and adrenaline from the adrenal medulla in rats.
    Shimizu T; Yokotani K
    Eur J Pharmacol; 2009 Mar; 606(1-3):77-83. PubMed ID: 19374850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Homoepiboxidines: further potent agonists for nicotinic receptors.
    Fitch RW; Pei XF; Kaneko Y; Gupta T; Shi D; Federova I; Daly JW
    Bioorg Med Chem; 2004 Jan; 12(1):179-90. PubMed ID: 14697783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [125I]IPH, an epibatidine analog, binds with high affinity to neuronal nicotinic cholinergic receptors.
    Dávila-García MI; Musachio JL; Perry DC; Xiao Y; Horti A; London ED; Dannals RF; Kellar KJ
    J Pharmacol Exp Ther; 1997 Jul; 282(1):445-51. PubMed ID: 9223586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epibatidine and its analogues as nicotinic acetylcholine receptor agonist: an update.
    Yogeeswari P; Sriram D; Ratan Bal T; Thirumurugan R
    Nat Prod Res; 2006 May; 20(5):497-505. PubMed ID: 16644549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A-85380 [3-(2(S)-azetidinylmethoxy) pyridine]: in vitro pharmacological properties of a novel, high affinity alpha 4 beta 2 nicotinic acetylcholine receptor ligand.
    Sullivan JP; Donnelly-Roberts D; Briggs CA; Anderson DJ; Gopalakrishnan M; Piattoni-Kaplan M; Campbell JE; McKenna DG; Molinari E; Hettinger AM; Garvey DS; Wasicak JT; Holladay MW; Williams M; Arneric SP
    Neuropharmacology; 1996 Jun; 35(6):725-34. PubMed ID: 8887981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural basis for epibatidine selectivity at desensitized nicotinic receptors.
    Pennington RA; Gao F; Sine SM; Prince RJ
    Mol Pharmacol; 2005 Jan; 67(1):123-31. PubMed ID: 15496507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacogenetic variability in neuronal nicotinic receptor-mediated antinociception.
    Flores CM; Wilson SG; Mogil JS
    Pharmacogenetics; 1999 Oct; 9(5):619-25. PubMed ID: 10591542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of Bay K 8644 treatment on (+/-)-epibatidine-induced analgesia.
    Bannon AW; Gunther KL; Decker MW; Arneric SP
    Brain Res; 1995 Apr; 678(1-2):244-50. PubMed ID: 7542542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological distinctions between functional nicotinic acetylcholine receptors on the PC12 rat pheochromocytoma and the TE671 human medulloblastoma.
    Lukas RJ
    J Pharmacol Exp Ther; 1989 Oct; 251(1):175-82. PubMed ID: 2571716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and initial structure-activity relationships of (R)-5-(2-azetidinylmethoxy)-2-chloropyridine (ABT-594), a potent, orally active, non-opiate analgesic agent acting via neuronal nicotinic acetylcholine receptors.
    Holladay MW; Wasicak JT; Lin NH; He Y; Ryther KB; Bannon AW; Buckley MJ; Kim DJ; Decker MW; Anderson DJ; Campbell JE; Kuntzweiler TA; Donnelly-Roberts DL; Piattoni-Kaplan M; Briggs CA; Williams M; Arneric SP
    J Med Chem; 1998 Feb; 41(4):407-12. PubMed ID: 9484491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absolute Configuration and Pharmacology of the Poison Frog Alkaloid Phantasmidine.
    Fitch RW; Snider BB; Zhou Q; Foxman BM; Pandya AA; Yakel JL; Olson TT; Al-Muhtasib N; Xiao Y; Welch KD; Panter KE
    J Nat Prod; 2018 Apr; 81(4):1029-1035. PubMed ID: 29671588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization.
    Arneric SP; Sullivan JP; Briggs CA; Donnelly-Roberts D; Anderson DJ; Raszkiewicz JL; Hughes ML; Cadman ED; Adams P; Garvey DS
    J Pharmacol Exp Ther; 1994 Jul; 270(1):310-8. PubMed ID: 7518514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epibatidine activates muscle acetylcholine receptors with unique site selectivity.
    Prince RJ; Sine SM
    Biophys J; 1998 Oct; 75(4):1817-27. PubMed ID: 9746523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 6'-Methylpyrido[3,4-b]norhomotropane: synthesis and outstanding potency in relation to the alpha4beta2 nicotinic receptor pharmacophore model.
    Kanne DB; Tomizawa M; Durkin KA; Casida JE
    Bioorg Med Chem Lett; 2005 Feb; 15(4):877-81. PubMed ID: 15686879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of (+/-)-epibatidine, a nicotinic agonist, on the central pathways controlling voiding function in the rat.
    Lee SJ; Nakamura Y; de Groat WC
    Am J Physiol Regul Integr Comp Physiol; 2003 Jul; 285(1):R84-90. PubMed ID: 12689850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Epibatidine. An old work principle rediscovered].
    Hecker T; Nieber K
    Med Monatsschr Pharm; 1999 Aug; 22(8):226-32. PubMed ID: 10481433
    [No Abstract]   [Full Text] [Related]  

  • 38. Homoanatoxin: a potent analogue of anatoxin-A.
    Wonnacott S; Swanson KL; Albuquerque EX; Huby NJ; Thompson P; Gallagher T
    Biochem Pharmacol; 1992 Feb; 43(3):419-23. PubMed ID: 1540199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is epibatidine really analgesic? Dissociation of the activity, temperature, and analgesic effects of (+/-)-epibatidine.
    Bannon AW; Gunther KL; Decker MW
    Pharmacol Biochem Behav; 1995 Aug; 51(4):693-8. PubMed ID: 7675845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and electrophysiological studies of a novel epibatidine analogue.
    Spang JE; Patt JT; Bertrand S; Bertrand D; Westera G; Schubiger PA
    J Recept Signal Transduct Res; 1999; 19(1-4):521-31. PubMed ID: 10071782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.